Burning Rock Biotech Ltd
NASDAQ:BNR
Burning Rock Biotech Ltd
Total Receivables
Burning Rock Biotech Ltd
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Burning Rock Biotech Ltd
NASDAQ:BNR
|
Total Receivables
¥149.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Total Receivables
¥3.2B
|
CAGR 3-Years
77%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Total Receivables
¥1B
|
CAGR 3-Years
28%
|
CAGR 5-Years
116%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Total Receivables
¥3.1B
|
CAGR 3-Years
62%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Total Receivables
¥27.1B
|
CAGR 3-Years
50%
|
CAGR 5-Years
53%
|
CAGR 10-Years
49%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Total Receivables
¥142.9m
|
CAGR 3-Years
75%
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
See Also
What is Burning Rock Biotech Ltd's Total Receivables?
Total Receivables
149.6m
CNY
Based on the financial report for Dec 31, 2023, Burning Rock Biotech Ltd's Total Receivables amounts to 149.6m CNY.
What is Burning Rock Biotech Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
13%
Over the last year, the Total Receivables growth was -12%. The average annual Total Receivables growth rates for Burning Rock Biotech Ltd have been 1% over the past three years , 13% over the past five years .